missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Recombinant Human CXCL13/BLC/BCA-1 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

N.V.

Spezifikation

Gen-ID (Entrez) 10563
Molekulargewicht 8.7 kDa
Name CXCL13/BLC/BCA-1
Menge 25μg
Quelle E. coli-derived human CXCL13/BLC/BCA-1 protein Val23-Arg94
Mehr Spezifikationen ansehen

Beschreibung

Beschreibung

The Recombinant Human CXCL13/BLC/BCA-1 Protein is derived from E. coli. The Recombinant Human CXCL13/BLC/BCA-1 Protein has been validated for the following applications: Bioactivity.
Spezifikation

Spezifikation

10563
CXCL13/BLC/BCA-1
E. coli-derived human CXCL13/BLC/BCA-1 protein Val23-Arg94
ANGIE, ANGIE2, B cell-attracting chemokine 1, B lymphocyte chemoattractant, BCA1, BCA-1, BCA1B-cell chemoattractant, BCA-1CXC chemokine BLC, B-cell-homing chemokine (ligand for Burkitt's lymphoma receptor-1), BLC, BLCSmall-inducible cytokine B13, BLR1L, B-lymphocyte chemoattractant, chemokine (C-X-C motif) ligand 13, chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant), C-X-C motif chemokine 13, SCYB13, SCYB13B-cell-attracting chemokine 1, small inducible cytokine B subfamily (Cys-X-Cys motif), member 13 (B-cellchemoattractant)
Recombinant
8.7 kDa
25μg
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
Unconjugated
95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Produktzertifizierungen